Partial hold placed on trial of drug for AML, MDSAugust 18, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Study links communication, outcomes in cancerAugust 15, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Auto-HSCT linked to higher AML, MDS riskAugust 14, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLMyelodysplastic Syndrome
Familial risk of myeloid malignanciesAugust 13, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Group releases new CLL guidelinesAugust 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Team recommends melanoma screening in CLLAugust 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Frequent BCCs linked to blood cancersAugust 9, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Treatment guidelines for CAR T-cell therapyAugust 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Method may enable eradication of LSCs in AMLAugust 3, 2018Leukemia, Myelodysplasia, TransplantationAML
Adult CCSs report financial hardshipsAugust 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Inhibitor receives breakthrough designation for AMLAugust 2, 2018Leukemia, Myelodysplasia, TransplantationAML